nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Donepezil—Alzheimer's disease	0.121	1	CbGbCtD
Epoprostenol—PTGIS—blood vessel—Alzheimer's disease	0.0236	0.191	CbGeAlD
Epoprostenol—PTGIR—blood vessel—Alzheimer's disease	0.0136	0.11	CbGeAlD
Epoprostenol—P2RY12—forebrain—Alzheimer's disease	0.0112	0.0906	CbGeAlD
Epoprostenol—PTGIR—forebrain—Alzheimer's disease	0.00716	0.0578	CbGeAlD
Epoprostenol—PTGIS—nervous system—Alzheimer's disease	0.00677	0.0546	CbGeAlD
Epoprostenol—PTGIR—telencephalon—Alzheimer's disease	0.00658	0.0532	CbGeAlD
Epoprostenol—PTGIS—central nervous system—Alzheimer's disease	0.00652	0.0526	CbGeAlD
Epoprostenol—PTGER1—nervous system—Alzheimer's disease	0.00629	0.0508	CbGeAlD
Epoprostenol—P2RY12—nervous system—Alzheimer's disease	0.00609	0.0492	CbGeAlD
Epoprostenol—PTGER1—central nervous system—Alzheimer's disease	0.00606	0.0489	CbGeAlD
Epoprostenol—P2RY12—central nervous system—Alzheimer's disease	0.00587	0.0474	CbGeAlD
Epoprostenol—PTGIS—brain—Alzheimer's disease	0.00517	0.0418	CbGeAlD
Epoprostenol—P2RY12—brain—Alzheimer's disease	0.00466	0.0376	CbGeAlD
Epoprostenol—PTGIR—nervous system—Alzheimer's disease	0.00389	0.0314	CbGeAlD
Epoprostenol—PTGIR—central nervous system—Alzheimer's disease	0.00374	0.0302	CbGeAlD
Epoprostenol—PTGIR—cerebellum—Alzheimer's disease	0.00366	0.0295	CbGeAlD
Epoprostenol—PTGIR—brain—Alzheimer's disease	0.00297	0.024	CbGeAlD
Epoprostenol—Syncope—Galantamine—Alzheimer's disease	0.00129	0.00266	CcSEcCtD
Epoprostenol—Haemoglobin—Donepezil—Alzheimer's disease	0.00129	0.00265	CcSEcCtD
Epoprostenol—Weight decreased—Rivastigmine—Alzheimer's disease	0.00128	0.00265	CcSEcCtD
Epoprostenol—Rhinitis—Donepezil—Alzheimer's disease	0.00128	0.00264	CcSEcCtD
Epoprostenol—Haemorrhage—Donepezil—Alzheimer's disease	0.00128	0.00264	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00128	0.00263	CcSEcCtD
Epoprostenol—Pneumonia—Rivastigmine—Alzheimer's disease	0.00127	0.00263	CcSEcCtD
Epoprostenol—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00127	0.00262	CcSEcCtD
Epoprostenol—Palpitations—Galantamine—Alzheimer's disease	0.00127	0.00262	CcSEcCtD
Epoprostenol—Pharyngitis—Donepezil—Alzheimer's disease	0.00127	0.00262	CcSEcCtD
Epoprostenol—Myocardial infarction—Memantine—Alzheimer's disease	0.00127	0.00262	CcSEcCtD
Epoprostenol—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00127	0.00261	CcSEcCtD
Epoprostenol—Infestation—Rivastigmine—Alzheimer's disease	0.00127	0.00261	CcSEcCtD
Epoprostenol—Loss of consciousness—Galantamine—Alzheimer's disease	0.00126	0.0026	CcSEcCtD
Epoprostenol—Depression—Rivastigmine—Alzheimer's disease	0.00126	0.0026	CcSEcCtD
Epoprostenol—Oedema peripheral—Donepezil—Alzheimer's disease	0.00126	0.0026	CcSEcCtD
Epoprostenol—Urinary tract infection—Memantine—Alzheimer's disease	0.00126	0.00259	CcSEcCtD
Epoprostenol—Cough—Galantamine—Alzheimer's disease	0.00125	0.00259	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00125	0.00257	CcSEcCtD
Epoprostenol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00124	0.00256	CcSEcCtD
Epoprostenol—Haematuria—Memantine—Alzheimer's disease	0.00123	0.00254	CcSEcCtD
Epoprostenol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00123	0.00254	CcSEcCtD
Epoprostenol—Arthralgia—Galantamine—Alzheimer's disease	0.00122	0.00252	CcSEcCtD
Epoprostenol—Chest pain—Galantamine—Alzheimer's disease	0.00122	0.00252	CcSEcCtD
Epoprostenol—Myalgia—Galantamine—Alzheimer's disease	0.00122	0.00252	CcSEcCtD
Epoprostenol—Epistaxis—Memantine—Alzheimer's disease	0.00122	0.00252	CcSEcCtD
Epoprostenol—Anxiety—Galantamine—Alzheimer's disease	0.00122	0.00251	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00121	0.00251	CcSEcCtD
Epoprostenol—Sinusitis—Memantine—Alzheimer's disease	0.00121	0.0025	CcSEcCtD
Epoprostenol—Sweating—Rivastigmine—Alzheimer's disease	0.00121	0.0025	CcSEcCtD
Epoprostenol—Haematuria—Rivastigmine—Alzheimer's disease	0.00121	0.00249	CcSEcCtD
Epoprostenol—Dry mouth—Galantamine—Alzheimer's disease	0.0012	0.00247	CcSEcCtD
Epoprostenol—Epistaxis—Rivastigmine—Alzheimer's disease	0.00119	0.00246	CcSEcCtD
Epoprostenol—Sinusitis—Rivastigmine—Alzheimer's disease	0.00119	0.00245	CcSEcCtD
Epoprostenol—Confusional state—Galantamine—Alzheimer's disease	0.00118	0.00244	CcSEcCtD
Epoprostenol—Bradycardia—Memantine—Alzheimer's disease	0.00118	0.00244	CcSEcCtD
Epoprostenol—Haemoglobin—Memantine—Alzheimer's disease	0.00117	0.00241	CcSEcCtD
Epoprostenol—Rhinitis—Memantine—Alzheimer's disease	0.00116	0.0024	CcSEcCtD
Epoprostenol—Haemorrhage—Memantine—Alzheimer's disease	0.00116	0.0024	CcSEcCtD
Epoprostenol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00116	0.00239	CcSEcCtD
Epoprostenol—Hypoaesthesia—Memantine—Alzheimer's disease	0.00116	0.00238	CcSEcCtD
Epoprostenol—Shock—Galantamine—Alzheimer's disease	0.00115	0.00238	CcSEcCtD
Epoprostenol—Pharyngitis—Memantine—Alzheimer's disease	0.00115	0.00238	CcSEcCtD
Epoprostenol—Nervous system disorder—Galantamine—Alzheimer's disease	0.00115	0.00237	CcSEcCtD
Epoprostenol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00115	0.00237	CcSEcCtD
Epoprostenol—Chills—Donepezil—Alzheimer's disease	0.00115	0.00237	CcSEcCtD
Epoprostenol—Tachycardia—Galantamine—Alzheimer's disease	0.00114	0.00236	CcSEcCtD
Epoprostenol—Oedema peripheral—Memantine—Alzheimer's disease	0.00114	0.00236	CcSEcCtD
Epoprostenol—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00114	0.00236	CcSEcCtD
Epoprostenol—Connective tissue disorder—Memantine—Alzheimer's disease	0.00114	0.00235	CcSEcCtD
Epoprostenol—Rhinitis—Rivastigmine—Alzheimer's disease	0.00114	0.00235	CcSEcCtD
Epoprostenol—Skin disorder—Galantamine—Alzheimer's disease	0.00114	0.00235	CcSEcCtD
Epoprostenol—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00114	0.00234	CcSEcCtD
Epoprostenol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00113	0.00234	CcSEcCtD
Epoprostenol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00113	0.00233	CcSEcCtD
Epoprostenol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00113	0.00233	CcSEcCtD
Epoprostenol—Mental disorder—Donepezil—Alzheimer's disease	0.00112	0.00231	CcSEcCtD
Epoprostenol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00112	0.00231	CcSEcCtD
Epoprostenol—Anorexia—Galantamine—Alzheimer's disease	0.00112	0.00231	CcSEcCtD
Epoprostenol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00112	0.0023	CcSEcCtD
Epoprostenol—Flatulence—Donepezil—Alzheimer's disease	0.0011	0.00226	CcSEcCtD
Epoprostenol—Hypotension—Galantamine—Alzheimer's disease	0.0011	0.00226	CcSEcCtD
Epoprostenol—Tension—Donepezil—Alzheimer's disease	0.00109	0.00225	CcSEcCtD
Epoprostenol—Nervousness—Donepezil—Alzheimer's disease	0.00108	0.00223	CcSEcCtD
Epoprostenol—Cardiac disorder—Memantine—Alzheimer's disease	0.00108	0.00222	CcSEcCtD
Epoprostenol—Flushing—Memantine—Alzheimer's disease	0.00108	0.00222	CcSEcCtD
Epoprostenol—Back pain—Donepezil—Alzheimer's disease	0.00108	0.00222	CcSEcCtD
Epoprostenol—Muscle spasms—Donepezil—Alzheimer's disease	0.00107	0.00221	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00107	0.0022	CcSEcCtD
Epoprostenol—Insomnia—Galantamine—Alzheimer's disease	0.00106	0.00219	CcSEcCtD
Epoprostenol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00105	0.00217	CcSEcCtD
Epoprostenol—Flushing—Rivastigmine—Alzheimer's disease	0.00105	0.00217	CcSEcCtD
Epoprostenol—Angiopathy—Memantine—Alzheimer's disease	0.00105	0.00217	CcSEcCtD
Epoprostenol—Paraesthesia—Galantamine—Alzheimer's disease	0.00105	0.00217	CcSEcCtD
Epoprostenol—Mediastinal disorder—Memantine—Alzheimer's disease	0.00105	0.00216	CcSEcCtD
Epoprostenol—Tremor—Donepezil—Alzheimer's disease	0.00104	0.00215	CcSEcCtD
Epoprostenol—Somnolence—Galantamine—Alzheimer's disease	0.00104	0.00215	CcSEcCtD
Epoprostenol—Chills—Memantine—Alzheimer's disease	0.00104	0.00215	CcSEcCtD
Epoprostenol—Dyspepsia—Galantamine—Alzheimer's disease	0.00103	0.00213	CcSEcCtD
Epoprostenol—Angiopathy—Rivastigmine—Alzheimer's disease	0.00103	0.00213	CcSEcCtD
Epoprostenol—Anaemia—Donepezil—Alzheimer's disease	0.00103	0.00212	CcSEcCtD
Epoprostenol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00102	0.00211	CcSEcCtD
Epoprostenol—Agitation—Donepezil—Alzheimer's disease	0.00102	0.00211	CcSEcCtD
Epoprostenol—Chills—Rivastigmine—Alzheimer's disease	0.00102	0.0021	CcSEcCtD
Epoprostenol—Decreased appetite—Galantamine—Alzheimer's disease	0.00102	0.0021	CcSEcCtD
Epoprostenol—Mental disorder—Memantine—Alzheimer's disease	0.00102	0.0021	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00101	0.00209	CcSEcCtD
Epoprostenol—Fatigue—Galantamine—Alzheimer's disease	0.00101	0.00208	CcSEcCtD
Epoprostenol—Constipation—Galantamine—Alzheimer's disease	0.001	0.00207	CcSEcCtD
Epoprostenol—Syncope—Donepezil—Alzheimer's disease	0.000998	0.00206	CcSEcCtD
Epoprostenol—Flatulence—Memantine—Alzheimer's disease	0.000996	0.00205	CcSEcCtD
Epoprostenol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000995	0.00205	CcSEcCtD
Epoprostenol—Tension—Memantine—Alzheimer's disease	0.000992	0.00205	CcSEcCtD
Epoprostenol—Nervousness—Memantine—Alzheimer's disease	0.000982	0.00203	CcSEcCtD
Epoprostenol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000979	0.00202	CcSEcCtD
Epoprostenol—Back pain—Memantine—Alzheimer's disease	0.000978	0.00202	CcSEcCtD
Epoprostenol—Flatulence—Rivastigmine—Alzheimer's disease	0.000974	0.00201	CcSEcCtD
Epoprostenol—Cough—Donepezil—Alzheimer's disease	0.000972	0.002	CcSEcCtD
Epoprostenol—Tension—Rivastigmine—Alzheimer's disease	0.00097	0.002	CcSEcCtD
Epoprostenol—Nervousness—Rivastigmine—Alzheimer's disease	0.00096	0.00198	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000959	0.00198	CcSEcCtD
Epoprostenol—Back pain—Rivastigmine—Alzheimer's disease	0.000957	0.00197	CcSEcCtD
Epoprostenol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000951	0.00196	CcSEcCtD
Epoprostenol—Chest pain—Donepezil—Alzheimer's disease	0.000948	0.00196	CcSEcCtD
Epoprostenol—Arthralgia—Donepezil—Alzheimer's disease	0.000948	0.00196	CcSEcCtD
Epoprostenol—Myalgia—Donepezil—Alzheimer's disease	0.000948	0.00196	CcSEcCtD
Epoprostenol—Tremor—Memantine—Alzheimer's disease	0.000947	0.00195	CcSEcCtD
Epoprostenol—Anxiety—Donepezil—Alzheimer's disease	0.000945	0.00195	CcSEcCtD
Epoprostenol—Anaemia—Memantine—Alzheimer's disease	0.000934	0.00193	CcSEcCtD
Epoprostenol—Agitation—Memantine—Alzheimer's disease	0.000929	0.00192	CcSEcCtD
Epoprostenol—Dry mouth—Donepezil—Alzheimer's disease	0.000927	0.00191	CcSEcCtD
Epoprostenol—Abdominal pain—Galantamine—Alzheimer's disease	0.000927	0.00191	CcSEcCtD
Epoprostenol—Body temperature increased—Galantamine—Alzheimer's disease	0.000927	0.00191	CcSEcCtD
Epoprostenol—Tremor—Rivastigmine—Alzheimer's disease	0.000927	0.00191	CcSEcCtD
Epoprostenol—Confusional state—Donepezil—Alzheimer's disease	0.000916	0.00189	CcSEcCtD
Epoprostenol—Anaemia—Rivastigmine—Alzheimer's disease	0.000914	0.00189	CcSEcCtD
Epoprostenol—Agitation—Rivastigmine—Alzheimer's disease	0.000909	0.00187	CcSEcCtD
Epoprostenol—Oedema—Donepezil—Alzheimer's disease	0.000909	0.00187	CcSEcCtD
Epoprostenol—Syncope—Memantine—Alzheimer's disease	0.000907	0.00187	CcSEcCtD
Epoprostenol—Infection—Donepezil—Alzheimer's disease	0.000903	0.00186	CcSEcCtD
Epoprostenol—Shock—Donepezil—Alzheimer's disease	0.000894	0.00184	CcSEcCtD
Epoprostenol—Palpitations—Memantine—Alzheimer's disease	0.000893	0.00184	CcSEcCtD
Epoprostenol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000891	0.00184	CcSEcCtD
Epoprostenol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00089	0.00183	CcSEcCtD
Epoprostenol—Loss of consciousness—Memantine—Alzheimer's disease	0.000888	0.00183	CcSEcCtD
Epoprostenol—Syncope—Rivastigmine—Alzheimer's disease	0.000887	0.00183	CcSEcCtD
Epoprostenol—Cough—Memantine—Alzheimer's disease	0.000882	0.00182	CcSEcCtD
Epoprostenol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000878	0.00181	CcSEcCtD
Epoprostenol—Palpitations—Rivastigmine—Alzheimer's disease	0.000874	0.0018	CcSEcCtD
Epoprostenol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000869	0.00179	CcSEcCtD
Epoprostenol—Anorexia—Donepezil—Alzheimer's disease	0.000866	0.00179	CcSEcCtD
Epoprostenol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000864	0.00178	CcSEcCtD
Epoprostenol—Cough—Rivastigmine—Alzheimer's disease	0.000863	0.00178	CcSEcCtD
Epoprostenol—Myalgia—Memantine—Alzheimer's disease	0.000861	0.00178	CcSEcCtD
Epoprostenol—Arthralgia—Memantine—Alzheimer's disease	0.000861	0.00178	CcSEcCtD
Epoprostenol—Chest pain—Memantine—Alzheimer's disease	0.000861	0.00178	CcSEcCtD
Epoprostenol—Anxiety—Memantine—Alzheimer's disease	0.000858	0.00177	CcSEcCtD
Epoprostenol—Hypotension—Donepezil—Alzheimer's disease	0.000849	0.00175	CcSEcCtD
Epoprostenol—Chest pain—Rivastigmine—Alzheimer's disease	0.000842	0.00174	CcSEcCtD
Epoprostenol—Myalgia—Rivastigmine—Alzheimer's disease	0.000842	0.00174	CcSEcCtD
Epoprostenol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000842	0.00174	CcSEcCtD
Epoprostenol—Dry mouth—Memantine—Alzheimer's disease	0.000842	0.00174	CcSEcCtD
Epoprostenol—Asthenia—Galantamine—Alzheimer's disease	0.000841	0.00174	CcSEcCtD
Epoprostenol—Anxiety—Rivastigmine—Alzheimer's disease	0.000839	0.00173	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000836	0.00172	CcSEcCtD
Epoprostenol—Confusional state—Memantine—Alzheimer's disease	0.000832	0.00172	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000828	0.00171	CcSEcCtD
Epoprostenol—Oedema—Memantine—Alzheimer's disease	0.000825	0.0017	CcSEcCtD
Epoprostenol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000823	0.0017	CcSEcCtD
Epoprostenol—Insomnia—Donepezil—Alzheimer's disease	0.000822	0.0017	CcSEcCtD
Epoprostenol—Infection—Memantine—Alzheimer's disease	0.00082	0.00169	CcSEcCtD
Epoprostenol—Paraesthesia—Donepezil—Alzheimer's disease	0.000816	0.00168	CcSEcCtD
Epoprostenol—Confusional state—Rivastigmine—Alzheimer's disease	0.000814	0.00168	CcSEcCtD
Epoprostenol—Shock—Memantine—Alzheimer's disease	0.000812	0.00167	CcSEcCtD
Epoprostenol—Dyspnoea—Donepezil—Alzheimer's disease	0.00081	0.00167	CcSEcCtD
Epoprostenol—Nervous system disorder—Memantine—Alzheimer's disease	0.000809	0.00167	CcSEcCtD
Epoprostenol—Somnolence—Donepezil—Alzheimer's disease	0.000808	0.00167	CcSEcCtD
Epoprostenol—Thrombocytopenia—Memantine—Alzheimer's disease	0.000808	0.00167	CcSEcCtD
Epoprostenol—Oedema—Rivastigmine—Alzheimer's disease	0.000807	0.00166	CcSEcCtD
Epoprostenol—Tachycardia—Memantine—Alzheimer's disease	0.000805	0.00166	CcSEcCtD
Epoprostenol—Diarrhoea—Galantamine—Alzheimer's disease	0.000802	0.00165	CcSEcCtD
Epoprostenol—Infection—Rivastigmine—Alzheimer's disease	0.000802	0.00165	CcSEcCtD
Epoprostenol—Skin disorder—Memantine—Alzheimer's disease	0.000801	0.00165	CcSEcCtD
Epoprostenol—Dyspepsia—Donepezil—Alzheimer's disease	0.0008	0.00165	CcSEcCtD
Epoprostenol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000798	0.00165	CcSEcCtD
Epoprostenol—Shock—Rivastigmine—Alzheimer's disease	0.000794	0.00164	CcSEcCtD
Epoprostenol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000792	0.00163	CcSEcCtD
Epoprostenol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00079	0.00163	CcSEcCtD
Epoprostenol—Decreased appetite—Donepezil—Alzheimer's disease	0.00079	0.00163	CcSEcCtD
Epoprostenol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000788	0.00162	CcSEcCtD
Epoprostenol—Anorexia—Memantine—Alzheimer's disease	0.000786	0.00162	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000784	0.00162	CcSEcCtD
Epoprostenol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000784	0.00162	CcSEcCtD
Epoprostenol—Fatigue—Donepezil—Alzheimer's disease	0.000783	0.00162	CcSEcCtD
Epoprostenol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00078	0.00161	CcSEcCtD
Epoprostenol—Constipation—Donepezil—Alzheimer's disease	0.000777	0.0016	CcSEcCtD
Epoprostenol—Pain—Donepezil—Alzheimer's disease	0.000777	0.0016	CcSEcCtD
Epoprostenol—Dizziness—Galantamine—Alzheimer's disease	0.000775	0.0016	CcSEcCtD
Epoprostenol—Hypotension—Memantine—Alzheimer's disease	0.000771	0.00159	CcSEcCtD
Epoprostenol—Anorexia—Rivastigmine—Alzheimer's disease	0.000769	0.00159	CcSEcCtD
Epoprostenol—Hypotension—Rivastigmine—Alzheimer's disease	0.000754	0.00156	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000752	0.00155	CcSEcCtD
Epoprostenol—Insomnia—Memantine—Alzheimer's disease	0.000746	0.00154	CcSEcCtD
Epoprostenol—Vomiting—Galantamine—Alzheimer's disease	0.000745	0.00154	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000743	0.00153	CcSEcCtD
Epoprostenol—Paraesthesia—Memantine—Alzheimer's disease	0.000741	0.00153	CcSEcCtD
Epoprostenol—Rash—Galantamine—Alzheimer's disease	0.000739	0.00152	CcSEcCtD
Epoprostenol—Dermatitis—Galantamine—Alzheimer's disease	0.000739	0.00152	CcSEcCtD
Epoprostenol—Dyspnoea—Memantine—Alzheimer's disease	0.000736	0.00152	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000735	0.00152	CcSEcCtD
Epoprostenol—Headache—Galantamine—Alzheimer's disease	0.000735	0.00151	CcSEcCtD
Epoprostenol—Somnolence—Memantine—Alzheimer's disease	0.000733	0.00151	CcSEcCtD
Epoprostenol—Insomnia—Rivastigmine—Alzheimer's disease	0.00073	0.00151	CcSEcCtD
Epoprostenol—Dyspepsia—Memantine—Alzheimer's disease	0.000726	0.0015	CcSEcCtD
Epoprostenol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000725	0.00149	CcSEcCtD
Epoprostenol—Urticaria—Donepezil—Alzheimer's disease	0.000722	0.00149	CcSEcCtD
Epoprostenol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00072	0.00148	CcSEcCtD
Epoprostenol—Abdominal pain—Donepezil—Alzheimer's disease	0.000718	0.00148	CcSEcCtD
Epoprostenol—Body temperature increased—Donepezil—Alzheimer's disease	0.000718	0.00148	CcSEcCtD
Epoprostenol—Somnolence—Rivastigmine—Alzheimer's disease	0.000718	0.00148	CcSEcCtD
Epoprostenol—Decreased appetite—Memantine—Alzheimer's disease	0.000717	0.00148	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000712	0.00147	CcSEcCtD
Epoprostenol—Fatigue—Memantine—Alzheimer's disease	0.000711	0.00147	CcSEcCtD
Epoprostenol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00071	0.00147	CcSEcCtD
Epoprostenol—Pain—Memantine—Alzheimer's disease	0.000706	0.00146	CcSEcCtD
Epoprostenol—Constipation—Memantine—Alzheimer's disease	0.000706	0.00146	CcSEcCtD
Epoprostenol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000702	0.00145	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000697	0.00144	CcSEcCtD
Epoprostenol—Nausea—Galantamine—Alzheimer's disease	0.000696	0.00144	CcSEcCtD
Epoprostenol—Fatigue—Rivastigmine—Alzheimer's disease	0.000696	0.00144	CcSEcCtD
Epoprostenol—Constipation—Rivastigmine—Alzheimer's disease	0.00069	0.00142	CcSEcCtD
Epoprostenol—Pain—Rivastigmine—Alzheimer's disease	0.00069	0.00142	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000675	0.00139	CcSEcCtD
Epoprostenol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000669	0.00138	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00066	0.00136	CcSEcCtD
Epoprostenol—Urticaria—Memantine—Alzheimer's disease	0.000655	0.00135	CcSEcCtD
Epoprostenol—Abdominal pain—Memantine—Alzheimer's disease	0.000652	0.00135	CcSEcCtD
Epoprostenol—Body temperature increased—Memantine—Alzheimer's disease	0.000652	0.00135	CcSEcCtD
Epoprostenol—Asthenia—Donepezil—Alzheimer's disease	0.000652	0.00134	CcSEcCtD
Epoprostenol—Pruritus—Donepezil—Alzheimer's disease	0.000643	0.00133	CcSEcCtD
Epoprostenol—Urticaria—Rivastigmine—Alzheimer's disease	0.000641	0.00132	CcSEcCtD
Epoprostenol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000638	0.00132	CcSEcCtD
Epoprostenol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000638	0.00132	CcSEcCtD
Epoprostenol—Diarrhoea—Donepezil—Alzheimer's disease	0.000622	0.00128	CcSEcCtD
Epoprostenol—Hypersensitivity—Memantine—Alzheimer's disease	0.000608	0.00125	CcSEcCtD
Epoprostenol—Dizziness—Donepezil—Alzheimer's disease	0.000601	0.00124	CcSEcCtD
Epoprostenol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000595	0.00123	CcSEcCtD
Epoprostenol—Asthenia—Memantine—Alzheimer's disease	0.000592	0.00122	CcSEcCtD
Epoprostenol—Pruritus—Memantine—Alzheimer's disease	0.000584	0.0012	CcSEcCtD
Epoprostenol—Asthenia—Rivastigmine—Alzheimer's disease	0.000579	0.00119	CcSEcCtD
Epoprostenol—Vomiting—Donepezil—Alzheimer's disease	0.000578	0.00119	CcSEcCtD
Epoprostenol—Rash—Donepezil—Alzheimer's disease	0.000573	0.00118	CcSEcCtD
Epoprostenol—Dermatitis—Donepezil—Alzheimer's disease	0.000572	0.00118	CcSEcCtD
Epoprostenol—Pruritus—Rivastigmine—Alzheimer's disease	0.000571	0.00118	CcSEcCtD
Epoprostenol—Headache—Donepezil—Alzheimer's disease	0.000569	0.00117	CcSEcCtD
Epoprostenol—Diarrhoea—Memantine—Alzheimer's disease	0.000564	0.00116	CcSEcCtD
Epoprostenol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000552	0.00114	CcSEcCtD
Epoprostenol—Dizziness—Memantine—Alzheimer's disease	0.000546	0.00113	CcSEcCtD
Epoprostenol—Nausea—Donepezil—Alzheimer's disease	0.00054	0.00111	CcSEcCtD
Epoprostenol—Dizziness—Rivastigmine—Alzheimer's disease	0.000534	0.0011	CcSEcCtD
Epoprostenol—Vomiting—Memantine—Alzheimer's disease	0.000525	0.00108	CcSEcCtD
Epoprostenol—Rash—Memantine—Alzheimer's disease	0.00052	0.00107	CcSEcCtD
Epoprostenol—Dermatitis—Memantine—Alzheimer's disease	0.00052	0.00107	CcSEcCtD
Epoprostenol—Headache—Memantine—Alzheimer's disease	0.000517	0.00107	CcSEcCtD
Epoprostenol—Vomiting—Rivastigmine—Alzheimer's disease	0.000513	0.00106	CcSEcCtD
Epoprostenol—Rash—Rivastigmine—Alzheimer's disease	0.000509	0.00105	CcSEcCtD
Epoprostenol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000508	0.00105	CcSEcCtD
Epoprostenol—Headache—Rivastigmine—Alzheimer's disease	0.000506	0.00104	CcSEcCtD
Epoprostenol—Nausea—Memantine—Alzheimer's disease	0.00049	0.00101	CcSEcCtD
Epoprostenol—Nausea—Rivastigmine—Alzheimer's disease	0.000479	0.000989	CcSEcCtD
Epoprostenol—PTGIS—Disease—CCR5—Alzheimer's disease	0.000123	0.000454	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	0.000123	0.000453	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARGC1A—Alzheimer's disease	0.000122	0.000453	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000122	0.000451	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—HMOX1—Alzheimer's disease	0.000122	0.000451	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NPY—Alzheimer's disease	0.000122	0.000449	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000122	0.000449	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PSEN2—Alzheimer's disease	0.000122	0.000449	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IAPP—Alzheimer's disease	0.000121	0.000446	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MTHFR—Alzheimer's disease	0.00012	0.000443	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CRH—Alzheimer's disease	0.000117	0.000433	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000117	0.000433	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000117	0.000433	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCR5—Alzheimer's disease	0.000116	0.000428	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000115	0.000424	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000115	0.000424	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000113	0.000418	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000112	0.000415	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000112	0.000415	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CALM1—Alzheimer's disease	0.000112	0.000414	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPY—Alzheimer's disease	0.000112	0.000413	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPY—Alzheimer's disease	0.000112	0.000413	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—APOE—Alzheimer's disease	0.000112	0.000413	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—LPL—Alzheimer's disease	0.000112	0.000412	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NPS—Alzheimer's disease	0.000111	0.000411	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IAPP—Alzheimer's disease	0.000111	0.000411	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IAPP—Alzheimer's disease	0.000111	0.000411	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000111	0.000409	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CAV1—Alzheimer's disease	0.000111	0.000409	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—F2—Alzheimer's disease	0.000109	0.000404	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTK2B—Alzheimer's disease	0.000109	0.000403	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CRH—Alzheimer's disease	0.000108	0.000399	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CRH—Alzheimer's disease	0.000108	0.000399	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCR5—Alzheimer's disease	0.000106	0.000394	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000106	0.000394	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GAB2—Alzheimer's disease	0.000106	0.000392	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SST—Alzheimer's disease	0.000106	0.000392	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NTRK2—Alzheimer's disease	0.000106	0.000392	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CALM1—Alzheimer's disease	0.000106	0.00039	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GSK3A—Alzheimer's disease	0.000105	0.000389	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000104	0.000385	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000104	0.000385	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS2—Alzheimer's disease	0.000104	0.000384	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APP—Alzheimer's disease	0.000103	0.000382	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOTCH1—Alzheimer's disease	0.000103	0.000381	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPS—Alzheimer's disease	0.000102	0.000378	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPS—Alzheimer's disease	0.000102	0.000378	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000102	0.000376	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000102	0.000376	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—F2—Alzheimer's disease	0.000101	0.000372	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—F2—Alzheimer's disease	0.000101	0.000372	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MTHFR—Alzheimer's disease	0.0001	0.000371	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTK2B—Alzheimer's disease	0.0001	0.000371	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTK2B—Alzheimer's disease	0.0001	0.000371	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—F2—Alzheimer's disease	9.92e-05	0.000367	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VEGFA—Alzheimer's disease	9.9e-05	0.000366	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NTRK2—Alzheimer's disease	9.76e-05	0.000361	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SST—Alzheimer's disease	9.76e-05	0.000361	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NTRK2—Alzheimer's disease	9.76e-05	0.000361	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GAB2—Alzheimer's disease	9.76e-05	0.000361	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SST—Alzheimer's disease	9.76e-05	0.000361	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GAB2—Alzheimer's disease	9.76e-05	0.000361	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PLCB1—Alzheimer's disease	9.75e-05	0.00036	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CALM1—Alzheimer's disease	9.72e-05	0.000359	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CALM1—Alzheimer's disease	9.72e-05	0.000359	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GSK3A—Alzheimer's disease	9.67e-05	0.000358	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GSK3A—Alzheimer's disease	9.67e-05	0.000358	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—GSK3B—Alzheimer's disease	9.67e-05	0.000357	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CREB1—Alzheimer's disease	9.59e-05	0.000354	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—INS—Alzheimer's disease	9.54e-05	0.000352	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APP—Alzheimer's disease	9.51e-05	0.000352	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APP—Alzheimer's disease	9.51e-05	0.000352	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CALM1—Alzheimer's disease	9.38e-05	0.000347	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—APOE—Alzheimer's disease	9.35e-05	0.000346	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CAV1—Alzheimer's disease	9.26e-05	0.000342	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—F2—Alzheimer's disease	9.13e-05	0.000338	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—F2—Alzheimer's disease	9.13e-05	0.000338	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—Alzheimer's disease	9.11e-05	0.000337	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NGFR—Alzheimer's disease	9.1e-05	0.000336	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TGFB1—Alzheimer's disease	9.08e-05	0.000336	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CREB1—Alzheimer's disease	9.04e-05	0.000334	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PLCB1—Alzheimer's disease	8.97e-05	0.000332	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PLCB1—Alzheimer's disease	8.97e-05	0.000332	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	8.95e-05	0.000331	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADAM10—Alzheimer's disease	8.89e-05	0.000328	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL2—Alzheimer's disease	8.85e-05	0.000327	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—S100B—Alzheimer's disease	8.4e-05	0.000311	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NGFR—Alzheimer's disease	8.37e-05	0.000309	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NGFR—Alzheimer's disease	8.37e-05	0.000309	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS3—Alzheimer's disease	8.36e-05	0.000309	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TGFB1—Alzheimer's disease	8.36e-05	0.000309	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.35e-05	0.000309	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CREB1—Alzheimer's disease	8.32e-05	0.000308	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CREB1—Alzheimer's disease	8.32e-05	0.000308	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADAM10—Alzheimer's disease	8.18e-05	0.000302	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADAM10—Alzheimer's disease	8.18e-05	0.000302	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARG—Alzheimer's disease	8.14e-05	0.000301	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL2—Alzheimer's disease	8.14e-05	0.000301	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL2—Alzheimer's disease	8.14e-05	0.000301	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF2—Alzheimer's disease	8e-05	0.000296	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—INS—Alzheimer's disease	7.99e-05	0.000295	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF1R—Alzheimer's disease	7.74e-05	0.000286	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—S100B—Alzheimer's disease	7.73e-05	0.000286	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—S100B—Alzheimer's disease	7.73e-05	0.000286	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—Alzheimer's disease	7.65e-05	0.000283	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CA4—Alzheimer's disease	7.61e-05	0.000281	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—Alzheimer's disease	7.48e-05	0.000276	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.44e-05	0.000275	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LPL—Alzheimer's disease	7.42e-05	0.000274	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF2—Alzheimer's disease	7.36e-05	0.000272	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF2—Alzheimer's disease	7.36e-05	0.000272	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MEF2C—Alzheimer's disease	7.35e-05	0.000272	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRKCG—Alzheimer's disease	7.21e-05	0.000267	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	7.16e-05	0.000265	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF1R—Alzheimer's disease	7.12e-05	0.000263	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF1R—Alzheimer's disease	7.12e-05	0.000263	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NGF—Alzheimer's disease	7.02e-05	0.00026	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NOS3—Alzheimer's disease	7e-05	0.000259	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—Alzheimer's disease	6.88e-05	0.000254	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR5—Alzheimer's disease	6.83e-05	0.000253	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LPL—Alzheimer's disease	6.83e-05	0.000252	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LPL—Alzheimer's disease	6.83e-05	0.000252	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	6.78e-05	0.000251	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MEF2C—Alzheimer's disease	6.76e-05	0.00025	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MEF2C—Alzheimer's disease	6.76e-05	0.00025	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR2A—Alzheimer's disease	6.69e-05	0.000247	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRKCG—Alzheimer's disease	6.64e-05	0.000245	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRKCG—Alzheimer's disease	6.64e-05	0.000245	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLD3—Alzheimer's disease	6.47e-05	0.000239	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.47e-05	0.000239	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NGF—Alzheimer's disease	6.46e-05	0.000239	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NGF—Alzheimer's disease	6.46e-05	0.000239	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—Alzheimer's disease	6.41e-05	0.000237	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.4e-05	0.000236	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—AKT1—Alzheimer's disease	6.32e-05	0.000233	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR5—Alzheimer's disease	6.29e-05	0.000232	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR5—Alzheimer's disease	6.29e-05	0.000232	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CALM1—Alzheimer's disease	6.24e-05	0.000231	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LEP—Alzheimer's disease	6.22e-05	0.00023	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APOE—Alzheimer's disease	6.22e-05	0.00023	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	6.21e-05	0.000229	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CAV1—Alzheimer's disease	6.16e-05	0.000228	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR2A—Alzheimer's disease	6.15e-05	0.000227	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2A—Alzheimer's disease	6.15e-05	0.000227	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.06e-05	0.000224	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	5.97e-05	0.000221	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ESR1—Alzheimer's disease	5.94e-05	0.000219	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—F2—Alzheimer's disease	5.86e-05	0.000217	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—AKT1—Alzheimer's disease	5.81e-05	0.000215	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ND1—Alzheimer's disease	5.77e-05	0.000213	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CALM1—Alzheimer's disease	5.74e-05	0.000212	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CALM1—Alzheimer's disease	5.74e-05	0.000212	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOTCH1—Alzheimer's disease	5.74e-05	0.000212	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LEP—Alzheimer's disease	5.72e-05	0.000211	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LEP—Alzheimer's disease	5.72e-05	0.000211	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOE—Alzheimer's disease	5.72e-05	0.000211	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOE—Alzheimer's disease	5.72e-05	0.000211	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CAV1—Alzheimer's disease	5.67e-05	0.00021	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CAV1—Alzheimer's disease	5.67e-05	0.00021	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.64e-05	0.000208	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—Alzheimer's disease	5.53e-05	0.000204	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ESR1—Alzheimer's disease	5.46e-05	0.000202	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ESR1—Alzheimer's disease	5.46e-05	0.000202	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—F2—Alzheimer's disease	5.4e-05	0.000199	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—F2—Alzheimer's disease	5.4e-05	0.000199	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GSK3B—Alzheimer's disease	5.38e-05	0.000199	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CREB1—Alzheimer's disease	5.34e-05	0.000197	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—INS—Alzheimer's disease	5.31e-05	0.000196	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.28e-05	0.000195	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOTCH1—Alzheimer's disease	5.28e-05	0.000195	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—Alzheimer's disease	5.23e-05	0.000193	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.16e-05	0.000191	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF1—Alzheimer's disease	5.14e-05	0.00019	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GSK3B—Alzheimer's disease	4.95e-05	0.000183	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GSK3B—Alzheimer's disease	4.95e-05	0.000183	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CREB1—Alzheimer's disease	4.92e-05	0.000182	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CREB1—Alzheimer's disease	4.92e-05	0.000182	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—INS—Alzheimer's disease	4.89e-05	0.000181	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—INS—Alzheimer's disease	4.89e-05	0.000181	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—Alzheimer's disease	4.81e-05	0.000178	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—Alzheimer's disease	4.81e-05	0.000178	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF1—Alzheimer's disease	4.73e-05	0.000175	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF1—Alzheimer's disease	4.73e-05	0.000175	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—Alzheimer's disease	4.66e-05	0.000172	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.44e-05	0.000164	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—Alzheimer's disease	4.29e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—Alzheimer's disease	4.29e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—Alzheimer's disease	4.17e-05	0.000154	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.05e-05	0.00015	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AKT1—Alzheimer's disease	3.99e-05	0.000148	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CASP3—Alzheimer's disease	3.95e-05	0.000146	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—Alzheimer's disease	3.93e-05	0.000145	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—AKT1—Alzheimer's disease	3.84e-05	0.000142	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—TPI1—Alzheimer's disease	3.72e-05	0.000137	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CHAT—Alzheimer's disease	3.72e-05	0.000137	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.67e-05	0.000136	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AKT1—Alzheimer's disease	3.67e-05	0.000136	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CASP3—Alzheimer's disease	3.64e-05	0.000135	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CASP3—Alzheimer's disease	3.64e-05	0.000135	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK8—Alzheimer's disease	3.63e-05	0.000134	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AKT1—Alzheimer's disease	3.62e-05	0.000134	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—Alzheimer's disease	3.62e-05	0.000134	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—Alzheimer's disease	3.62e-05	0.000134	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MAOB—Alzheimer's disease	3.56e-05	0.000132	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	3.43e-05	0.000127	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.39e-05	0.000125	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.36e-05	0.000124	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—Alzheimer's disease	3.36e-05	0.000124	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK8—Alzheimer's disease	3.34e-05	0.000124	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK8—Alzheimer's disease	3.34e-05	0.000124	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AKT1—Alzheimer's disease	3.34e-05	0.000123	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AKT1—Alzheimer's disease	3.34e-05	0.000123	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—A2M—Alzheimer's disease	3.31e-05	0.000122	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AKT1—Alzheimer's disease	3.22e-05	0.000119	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—Alzheimer's disease	3.09e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—Alzheimer's disease	3.09e-05	0.000114	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—Alzheimer's disease	3.08e-05	0.000114	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.95e-05	0.000109	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACHE—Alzheimer's disease	2.88e-05	0.000107	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	2.85e-05	0.000105	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—Alzheimer's disease	2.83e-05	0.000105	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—Alzheimer's disease	2.83e-05	0.000105	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	2.7e-05	9.98e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ENO1—Alzheimer's disease	2.7e-05	9.98e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	2.65e-05	9.79e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—Alzheimer's disease	2.54e-05	9.37e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.51e-05	9.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.37e-05	8.76e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—Alzheimer's disease	2.33e-05	8.62e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—Alzheimer's disease	2.33e-05	8.62e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.32e-05	8.59e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—Alzheimer's disease	2.32e-05	8.58e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.3e-05	8.49e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT1—Alzheimer's disease	2.14e-05	7.91e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—Alzheimer's disease	2.14e-05	7.89e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—Alzheimer's disease	2.14e-05	7.89e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.98e-05	7.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.97e-05	7.28e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT1—Alzheimer's disease	1.97e-05	7.28e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT1—Alzheimer's disease	1.97e-05	7.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.8e-05	6.66e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.62e-05	6e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.52e-05	5.6e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.51e-05	5.58e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.5e-05	5.53e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.32e-05	4.86e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—INS—Alzheimer's disease	1.29e-05	4.77e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.13e-05	4.18e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.04e-05	3.83e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.2e-06	1.92e-05	CbGpPWpGaD
